At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 113 enrolled
Drug / intervention
Stannous Fluoride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Short Term Relief From Dentinal Hypersensitivity
In Brief
A Phase 3 clinical trial evaluating Stannous Fluoride and Sodium Monofluorophosphate for Dentine Hypersensitivity. Completed, enrolled 113 participants across 1 site.
Detailed Summary
A study to compare the efficacy of a test dentifrice against a control dentifrice in reducing dentinal hypersensitivity over a two week treatment period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentine Hypersensitivity
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2012
Primary CompletionMay 2012
First PostedMay 2012
TodayJul 2026
First PostedMay 7, 2012
Enrollment StartApr 1, 2012
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.2 years ago
Interventions
Stannous Fluoridedrug
dentifrice containing stannous fluoride
Sodium Monofluorophosphatedrug
dentifrice containing Sodium Monofluorophosphate